Simetić, L., Blažević, K., Međugorac, K., Golčić, M. i Herceg, D. (2020). Relative Change in S100 as a Biomarker of Survival
in Patients With Metastatic Melanoma. Anticancer Research, 40. (4), 2157-2163. doi: 10.21873/anticanres.14175
Simetić, Luka, et al. "Relative Change in S100 as a Biomarker of Survival
in Patients With Metastatic Melanoma." Anticancer Research, vol. 40, br. 4, 2020, str. 2157-2163. https://doi.org/10.21873/anticanres.14175
Simetić, Luka, Krešimir Blažević, Kata Međugorac, Marin Golčić i Davorin Herceg. "Relative Change in S100 as a Biomarker of Survival
in Patients With Metastatic Melanoma." Anticancer Research 40, br. 4 (2020): 2157-2163. https://doi.org/10.21873/anticanres.14175
Simetić, L., et al. (2020) 'Relative Change in S100 as a Biomarker of Survival
in Patients With Metastatic Melanoma', Anticancer Research, 40(4), str. 2157-2163. doi: 10.21873/anticanres.14175
Simetić L, Blažević K, Međugorac K, Golčić M, Herceg D. Relative Change in S100 as a Biomarker of Survival
in Patients With Metastatic Melanoma. Anticancer Research [Internet]. 2020. [pristupljeno 20.08.2024.];40(4):2157-2163. doi: 10.21873/anticanres.14175
L. Simetić, K. Blažević, K. Međugorac, M. Golčić i D. Herceg, "Relative Change in S100 as a Biomarker of Survival
in Patients With Metastatic Melanoma", Anticancer Research, vol. 40, br. 4, str. 2157-2163, 2020. [Online]. Dostupno na: https://urn.nsk.hr/urn:nbn:hr:184:392410. [Citirano: 20.08.2024.]